Account
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Insider Insights
29.09.2023
Switzerland's 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...

Read more
Case Studies
26.04.2023
Development and refinement of payer value messages

Conduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...

Read more
Case Studies
26.04.2023
Our client wanted to gain an understanding

Our client wanted to gain an understanding of payer willingness to pay and determine the likely clin...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client wanted to understand the clinical and economic evidence requirements that drive payer dec...

Read more
Articles
03.04.2023
What is the joint clinical assessment and what doe...

We explore what the joint clinical assessment (JCA) is, its process and what future developments may...

Read more
Case Studies
27.01.2023
Payer value proposition development

Payer value proposition development and understanding evidence requirements to secure pricing and re...

Read more
Articles
11.01.2023
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Insider Insights
01.02.2022
Voluntary payment percentage set at 15

All other aspects of the voluntary scheme remain unchanged.

Read more
Insider Insights
01.02.2022
Proposals for reforming public and private health

The report looks at four possible scenarios including most notably the creation of a “grande Sécu...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.